Nifty 17026.45 (-2.91%)
Sensex 57107.15 (-2.87%)
Nifty Bank 36025.5 (-3.58%)
Nifty IT 34606.1 (-1.97%)
Nifty Financial Services 17614.7 (-3.56%)
Adani Ports 717.15 (-5.94%)
Asian Paints 3143.10 (-0.04%)
Axis Bank 661.75 (-2.67%)
B P C L 376.85 (-5.81%)
Bajaj Auto 3334.60 (-1.68%)
Bajaj Finance 6807.05 (-4.47%)
Bajaj Finserv 16682.55 (-3.95%)
Bharti Airtel 738.75 (-3.45%)
Britannia Inds. 3555.30 (-0.51%)
Cipla 966.70 (7.42%)
Coal India 155.90 (-1.67%)
Divis Lab. 4937.80 (2.88%)
Dr Reddys Labs 4750.90 (3.47%)
Eicher Motors 2433.90 (-3.43%)
Grasim Inds 1690.10 (-4.34%)
H D F C 2741.70 (-4.40%)
HCL Technologies 1110.05 (-1.31%)
HDFC Bank 1489.90 (-2.36%)
HDFC Life Insur. 670.65 (-2.64%)
Hero Motocorp 2529.40 (-2.52%)
Hind. Unilever 2335.10 (-0.59%)
Hindalco Inds. 417.00 (-6.72%)
I O C L 120.95 (-3.74%)
ICICI Bank 722.20 (-3.84%)
IndusInd Bank 901.80 (-5.99%)
Infosys 1691.65 (-1.79%)
ITC 224.00 (-3.16%)
JSW Steel 628.65 (-7.67%)
Kotak Mah. Bank 1964.30 (-3.48%)
Larsen & Toubro 1778.15 (-3.88%)
M & M 853.75 (-4.20%)
Maruti Suzuki 7170.50 (-5.31%)
Nestle India 19222.25 (0.23%)
NTPC 128.85 (-4.70%)
O N G C 147.10 (-5.16%)
Power Grid Corpn 202.00 (-1.10%)
Reliance Industr 2412.60 (-3.22%)
SBI Life Insuran 1130.35 (-2.51%)
Shree Cement 25945.80 (-2.72%)
St Bk of India 470.50 (-4.09%)
Sun Pharma.Inds. 767.30 (-1.99%)
Tata Consumer 766.70 (-5.09%)
Tata Motors 460.20 (-6.61%)
Tata Steel 1112.30 (-5.23%)
TCS 3446.85 (0.03%)
Tech Mahindra 1527.40 (-2.05%)
Titan Company 2292.30 (-4.40%)
UltraTech Cem. 7394.75 (-2.81%)
UPL 703.80 (-3.23%)
Wipro 621.45 (-2.40%)

Multibagger Alert: This plywood manufacturer has given investors a return of 256%

Multibagger Alert: This plywood manufacturer has given investors a return of 256%
by 5paisa Research Team 10/11/2021

On a YTD basis, the stock has given a return of 183%.

One of the largest plywood-makers in the country, Century Plyboards (India) Limited has given investors stellar returns of 256.67% over the last year. The share price stood at Rs 185.2 on November 9, 2020, and since then, the stock has more than doubled investor wealth.

The company recently reported its Q2 numbers, showcasing strong outperformance across all parameters. The company reported its best-ever net sales, EBITDA and net profit. Standalone net sales rose 55.5% YoY to Rs 808 crore led by an over 60% YoY growth in revenues in plywood and laminates followed by the particleboard (49% YoY) and MDF (36% YoY) segments. Overall, standalone operating profit stood at Rs 158.6 crore which was up 85.2% YoY and 162% sequentially.

Century Plyboards engages in the manufacture and sale of plywood, laminates, decorative veneers, pre-laminated boards, and flush doors. The management of the company has targetted Rs 5,000 crore in revenues by FY26 with an aggressive capex plan of Rs 1,230 crore that would be funded majorly through internal accruals. This would result in revenues growing at 19% CAGR over FY21-FY26.

The building materials industry was one of the many industries severely affected during the Covid-19 led lockdowns during Q1FY21 and it affected peak sales during the year. The high fixed cost structure of the industry dragged down the net earnings. However, the sector has been one of the fastest to recovery as lockdown restrictions were eased domestically. Companies such as Century Plyboards have seen a sharp improvement in capacity utilization levels and scaling up in revenues since June 2021. The industry is well on track to rebound with strong growth in FY22 and this is being reflected in the stock price of such companies.

At 1.13 pm on Wednesday, the stock is trading at Rs 646.70, down by 2.10% or Rs 13.85 per share on BSE. The 52-week high of the scrip is recorded at Rs 681.20 and the 52-week low at Rs 181 on the BSE.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Superstar Stocks: BTST Trading and stocks that could deliver good returns till November 11, 2021

Superstar Stocks: BTST Trading and stocks that could deliver good returns till November 11, 2021
by 5paisa Research Team 10/11/2021

Looking for stocks that could deliver good returns tomorrow, meet the superstar stocks for tomorrow Avenue Supermarts, Bharti Airtel and Delta Corp which are selected based on a three-factor model.

Many of the time market participants see a stock opening with a gap-up and wish they should have bought this superstar stock a day before to take advantage of the gap-up move. To fulfil this wish, we have come out with a unique system, which would help us to get the list of candidates that can be probable superstar stocks for tomorrow.

The superstock stocks for tomorrow selected are based on a three-factor prudent model, the first important factor for this model is price, the second key factor is pattern, and last but not least is the combination of momentum with volume. If a stock passes all these filters it would flash in our system and as a result, it would help traders to spot the superstar stocks for tomorrow at the right time!

Here are the superstar stocks for tomorrow.

Avenue Supermarts (DMART): The stock has jumped over 2.5% on a day where the market has been volatile, as a result, it has outperformed the broader as well as the benchmark indices. The stock has formed a sizable bullish candlestick pattern. The volume for the day has already surpassed its previous trading session volume and the activity has seen a sharp spike in the last one hour. The RSI is in the bullish territory on the hourly, daily and weekly time frame. The stock has the potential to reach levels of Rs 5045 on the upside and the level of Rs 4770 is immediate support for the stock.

Bharti Airtel: The stock of Bharti Airtel is seen outperforming on Wednesday as the stock has rallied over 2% and interestingly, it has been amongst the top two contributors to the Nifty50 index. The stock is on the verge of a breakout of stage-2 flat base pattern, however, higher volume was witnessed on Wednesday indicating larger participation in the direction of the trend. The RSI is in the bullish territory on the hourly, daily and weekly time frame. On the upside, the stock can test levels of Rs 750 and on the downside, the level of Rs 721 is seen as an important support for the stock.

Delta Corp: The stock of Delta Corp has witnessed a perfect trending day accompanied by above-average volume. The RSI is in the super bullish territory on the hourly, daily and weekly time frame. The stock could see levels of Rs 321, and support is placed at levels of Rs 295.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

This Pharma stock is the best defensive bet in a volatile market!

This Pharma stock is the best defensive bet in a volatile market!
by 5paisa Research Team 10/11/2021

Slug - In this undercurrent and high volatility scenario, the pharma sector is one of the go-to sectors for traders.

The past few weeks have been hugely volatile for the Indian benchmark indices. The corporate results season is on a roll and a lot of stocks have been corrected from their recent highs. The continuous FII selling is creating a panic among the market participants. In this undercurrent and high volatility scenario, the pharma sector is one of the go-to sectors for traders.

So, before we move forward towards this trending Pharma stock, let's take a look at the Nifty Pharma sector technical structure.

Nifty Pharma: The Overview

Nifty Pharma made a high of 14938 on October 4 and thereafter, it had witnessed a dip of nearly 9 per cent from the highs. it halted its down move around the important moving average i.e, 200-DMA, which is the most widely followed moving average by the long-term investors. Currently, the stock is trading in the range of 13600-14200. This sector was one of the top-performing sectors during the unprecedented Covid pandemic time and acted as the torchbearer for the Indian market.

Trending stock in the Pharma Sector.

Cipla: It is one of the leading companies in the Indian pharmaceutical sector with a market cap of Rs 74000 crore. The company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology, diabetes and critical care, etc. The stock has corrected about 12 per cent its recent high of Rs 1005. Its current PE stands at 28.47 while the sector PE stands at 38.6 indicating that the stock is not trading at a high premium. Earnings per share (EPS) is increasing consistently YoY.

The stock is currently trading near above its 200-DMA and interestingly, it has reclaimed its 20-DMA. Furthermore, despite the fact that the stock has witnessed a correction of over 10 per cent, the 14-period RSI has never entered into oversold territory and currently, it is above the 45-mark. The Bollinger bands have squeezed, which usually represents low volatility regime and we anticipate that a period of low volatility would be followed by high volatility.

Considering that the risk-reward is quite favourable at current levels, traders can keep this stock on their watchlist. It is one of the attractive bets of the Indian pharmaceutical industry.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

FIIs cut stake in many large cap stocks in Q2. Find out more

by 5paisa Research Team 10/11/2021

India’s benchmark stock market indices have been consolidating near record highs over the past month and many investors have become cautious as they anticipate a correction from these levels. Indeed, foreign institutional investors (FIIs) have been net sellers in Indian equities in the current financial year to the tune of Rs 11,167 crore.

No wonder, then, that FIIs have been putting more money into large cap-stocks instead of betting on the riskier mid- and small-cap stocks over the past few months.

Quarterly shareholding data shows FIIs pushed up their stake in as many as 89 listed companies that have a valuation of $1 billion (Rs 7,500 crore) or more during the second quarter of this fiscal year. However, at the same time, they snipped their stake in as many as 87 firms with a valuation of at least $1 billion.

Also, FIIs cut stake in around four dozen large caps, or companies that currently have a market capitalisation of Rs 20,000 crore or more, during the July-September period.

Top large caps that saw FII selling

LIC Housing Finance saw the most distinct dilution of offshore investors’ stake. However, this was largely due to a preferential allotment to state-run Life Insurance Corp (LIC) that shrunk the shareholding of public investors.

However, FIIs also sold shares in LIC Housing Finance last quarter and brought down their aggregate holding from 145.3 million shares to 132.4 million shares. As a result, their combined stake fell from 28.8% to 24.07% last quarter.

The mortgage financier counted as many as 325 FII shareholders as of June 30. This number fell to 272 by September 30, stock-exchange data show.

Shriram Transport Finance, Sona BLW Precision, Lupin, SBI Life Insurance, Prestige Estates, UPL, Hero MotoCorp, Adani Green Energy, YES Bank, ICICI Lombard General Insurance, Aurobindo Pharma, Indraprastha Gas were among the large caps that reported a stake dilution of 2% or more by FIIs in the second quarter.

The offshore investors also turned bearish on top private banks and drugmakers, non-banking finance companies, Adani Group stocks, a few top-tier IT counters, steel producers and automakers.

These included HDFC Bank, ICICI Bank, HCL Technologies, Bajaj Finserv, ITC, Axis Bank, Adani Enterprises, Tata Motors, JSW Steel, Tech Mahindra, Vedanta, Bajaj Auto and Mahindra & Mahindra.

Other companies that saw an FII selloff during July-September were Godrej Consumer, BPCL, Britannia, Ambuja Cements, InterGlobe Aviation, IndusInd Bank, Dr. Reddy’s Labs, Muthoot Finance, Apollo Hospitals, Cholamandalam Investment, Bandhan Bank, Ashok Leyland, JSPL, Lupin, Oracle Financial, Oberoi Realty, Tata Communications, Dixon Technologies, Tube Investments, Deepak Nitrite, Torrent Power, Indian Bank and L&T Finance Holdings.

Several of these stocks also figured in the FII sell basket in the previous quarter. These included Tech Mahindra, commodities major Vedanta, automobile firms Hero MotoCorp and Mahindra & Mahindra, and BFSI stocks Shriram Transport Finance, SBI Life Insurance and YES Bank.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Q2 Earnings report: Can Bank of Baroda sustain the stellar Q1 performance?

Q2 Earnings report: Can Bank of Baroda sustain the stellar Q1 performance?
by 5paisa Research Team 10/11/2021

In the last three-months stock has rallied from Rs 78 to Rs 103.60 today, registering a return of 36.17%.

Bank of Baroda is an Indian multinational, public sector banking and financial services company. It currently has 8,192 branches in India and 99 overseas offices across 20 countries. The bank merged with Vijaya Bank and Dena Bank, effective 1st April 2019.

In the last three months stock has rallied from Rs 78 to Rs 103.60 today, registering a three-month return of 36.17%. This has happened exactly after Q1-results are out.

For Q1FY22, Net Interest income grew 15.8% YoY as domestic NIM improved 53bps YoY to 3.12%. This growth was mainly attributable to the decline in interest expenses to Rs 9,161 crore (-21.6% YoY), even as interest income de-grew 7.8% to Rs 17,053 crore.

Operating profit before provisions reached Rs 5,707 crore (+32.1% YoY). GNPA/NNPA was stable QoQ at 8.86%/3.03%. Domestic Deposits and Domestic Advances were down 2.4% and 2.3% sequentially. Access to low-cost borrowings and sufficient liquidity will help improve income growth as the credit demand returns.

Transfer NPAs to a bad bank to lower broad NPA numbers and aid recovery. Recent outlook upgrade by Moody’s on the Indian banking system to impact positively on Bank of Baroda as well.

Domestic Loan Book

Presently, corporate advances account for 46% of the loan book, followed by retail (21%), Agriculture (15%), MSME (15%) and others (3%).

Retail Book - Home loans account for 66% of the retail book, followed by auto loans (17%), others (12%) and education loans (5%).

International Business

International banking accounts for nearly 15% of the total business of the bank. It has achieved success in markets like East Africa. It has 101 overseas branches/offices across 21 countries. It operates in the UK, New Zealand, Kenya, Uganda, Guyana, Tanzania, Ghana, Botswana, Zambia, Malaysia and other countries. The Bank has one joint venture viz. India International Bank (Malaysia) Bhd. in Malaysia and one associate bank viz. Indo Zambia Bank Ltd. in Zambia with 30 branches.

Today, there is movement in stock price, at 2.50 PM stock is down by 4.70% in the anticipation of Q2-results. The company is reporting Q2-results at 4 PM today evening, 10 November 2021.

We have to wait and watch whether the company can carry the momentum with Q2-performance.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Meet the ace fund manager and investor: Samir Arora

Meet the ace fund manager and investor: Samir Arora
by 5paisa Research Team 10/11/2021

The founder of Helios Capital has made it big by capitalizing on enormous experience.

Samir Arora is widely recognized for being the founder and fund manager of Helios Capital. He is an ace investor and fund manager who is a trending personality in the Indian stock market. He completed his undergraduate degree in engineering from IIT Delhi after which he received his MBA with a gold medal from IIM Kolkata. He also holds a master’s degree in finance from Wharton School of the University of Pennsylvania, during which he secured the Dean’s scholarship. He used to work as a research analyst at Alliance Capital in New York.

Samir Arora came to Mumbai in 1993 and headed Alliance Capital’s Indian mutual fund business as chief investment officer till 2003. He also used to manage ACM India Liberalization Fund, an India-dedicated offshore fund, since its inception in 1993. He emerged as a highly decorated fund manager during this journey as he received numerous awards for fund management.

Later in 2005, he founded Helios Capital along with two other members, which currently manages both India focused long/short and long-only funds/mandates and a globally focused long-only fund. The fund utilizes a bottom-up approach for making investment decisions. The average investment horizon for the stocks is one to three years. Its portfolio mix with sufficient diversity has resulted in outperforming consistently across the years, cycles and phases of the market. The funds are driven by the following investment themes:

  • Compete with government-owned companies

  • Demographic/lifestyle changes

  • Factor cost advantage (IT/Pharma/Specialty chemicals)

In a recent interview with CNBC-TV18, he expressed to stay bullish on the Indian markets. Samir Arora is regarded as one of the highly experienced fund managers in India with a track record of more than 26 years of experience on the long side and over 15 years of experience on the short side. No wonder he is invited to so many interviews and TV shows to share his thoughts.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order